IP Library › Granted Patent US 6,864,069
Granted Patent B2
US 6,864,069 · App. 10/265,345 · Granted Mar 8, 2005

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,864,069
App. No.
10/265,345
Granted
Mar 8, 2005
Kind
B2
Abstract

The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.

Claims (3)

1. A polypeptide consisting of SEQ ID NO:25.

2. A pharmaceutical composition comprising the polypeptide of claim 1 in combination with a pharmaceutically acceptable carrier.

3. The polypeptide of claim 1 wherein said polypeptide is PEGylated.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 023027/0804 →